SEC 13F Intelligence

Managers / Q1 2021 · view latest →

DSAM Partners (London) Ltd

CIK 0001565061 · 14-15 CONDUIT STREET, LONDON, X0, W1S 2XJ · 442070168600

Reported Value
$539M
Q1 2021
Positions
47
Filings on Record
15
2019–present window
Filed
May 17, 2021
original filing

Summary

Dsam Partners (London) Ltd reported $539M in U.S.-listed holdings across 47 positions for Q1 2021.

Its largest position, GFL, represents 11.4% of the portfolio.

Compared with Q4 2020, the fund opened 20 new positions and exited 31.

Portfolio Metrics

Turnover
+33.0%
vs prior filed quarter
Top-10 Concentration
+61.6%
share of reported value
Largest Position
+11.4%
Gfl Environmental
New / Exited
20 / 31
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $692MQ1 ’19Q2 ’19: $805MQ3 ’19: $536MQ3 ’19Q4 ’19: $436MQ1 ’20: $423MQ1 ’20Q2 ’20: $383MQ3 ’20: $578MQ3 ’20Q4 ’20: $854MQ1 ’21: $539MQ1 ’21Q2 ’21: $595MQ3 ’21: $176MQ3 ’21filingsflow.com

Portfolio Composition

By security type
Common Stock: 79.1%Other: 18.5%ETP: 2.2%ADR: 0.3%
  • Common Stock · 79.1% · $426M
  • Other · 18.5% · $99M
  • ETP · 2.2% · $12M
  • ADR · 0.3% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
OXYOCCIDENTAL PETE CORPNEW+776.0K776.0K+$21M$21M
CSTMCONSTELLIUM SENEW+1.24M1.24M+$18M$18M
DECARBONIZATION PLUS ACQU CONEW+1.29M1.29M+$14M$14M
DMY TECHNOLOGY GROUP INC IVNEW+1.24M1.24M+$12M$12M
ACE CONVERGENCE ACQU CORPNEW+1.22M1.22M+$12M$12M
ONENEW+1.04M1.04M+$12M$12M
EEMISHARES TRNEW+220.0K220.0K+$12M$12M
TORTOISE ACQUISITION CORP IINEW+1.01M1.01M+$11M$11M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2021

46 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GFLGFL ENVIRONMENTAL INChistory →SUB VTG SHS11.37%$61M1.75M
2VNTVONTIER CORPORATIONhistory →COM7.44%$40M1.33M
3EXPEEXPEDIA GROUP INChistory →COM NEW7.20%$39M225.6K
4MUMICRON TECHNOLOGY INChistory →COM6.93%$37M423.8K
5ARANTERO RESOURCES CORPhistory →COM6.68%$36M3.53M
6GOOGALPHABET INChistory →CAP STK CL C5.35%$29M13.9K
7MSFTMICROSOFT CORPhistory →COM5.28%$28M120.8K
8ONON SEMICONDUCTOR CORPhistory →COM4.19%$23M543.0K
9OXYOCCIDENTAL PETE CORPhistory →COM3.83%$21M776.0K
10CSTMCONSTELLIUM SEhistory →CL A SHS3.37%$18M1.24M
11DECARBONIZATION PLUS ACQU COCOM CL A2.51%$14M1.29M
12DMY TECHNOLOGY GROUP INC IVUNIT 99/99/99992.31%$12M1.24M
13ACE CONVERGENCE ACQU CORPCL A2.26%$12M1.22M
14ONECOM CL A2.24%$12M1.04M
15TORTOISE ACQUISITION CORP IICOM CL A2.04%$11M1.01M
16CARRCARRIER GLOBAL CORPORATIONhistory →COM1.96%$11M250.9K
17BLUESCAPE OPPORTUNITIES ACQUUNIT 99/99/99991.64%$9M828.7K
18DMY TECHNOLOGY GROUP INC IIICOM CLASS A1.57%$8M786.8K
19FTCHQFARFETCH LTDhistory →ORD SH CL A1.33%$7M135.0K
20RHRHhistory →COM1.30%$7M11.7K
21ALLOALLOGENE THERAPEUTICS INChistory →COM1.21%$7M185.1K
22STAR PEAK ENERGY TRANSITIONCL A1.18%$6M239.0K
23RCKTROCKET PHARMACEUTICALS INChistory →COM1.15%$6M140.3K
24MLMMARTIN MARIETTA MATLS INChistory →COM1.04%$6M16.8K
25KRYSKRYSTAL BIOTECH INChistory →COM1.00%$5M70.3K
26NEXTGEN ACQUISITION CORPCL A0.97%$5M526.2K
27KRONOS BIO INCCOM0.96%$5M177.4K
28FOREST ROAD ACQUISITION CORPCOM0.92%$5M492.3K
29BBIOBRIDGEBIO PHARMA INCCOM0.92%$5M80.4K
30VMCVULCAN MATLS COCOM0.91%$5M29.0K
31HRTXHERON THERAPEUTICS INCCOM0.85%$5M283.4K
32MELIMERCADOLIBRE INCCOM0.76%$4M2.8K
33EPAMEPAM SYS INCCOM0.59%$3M8.0K
34RITCHIE BROS AUCTIONEERSCOM0.54%$3M50.0K
35CLDXCELLDEX THERAPEUTICS INC NEWCOM NEW0.52%$3M135.9K
36IOVAIOVANCE BIOTHERAPEUTICS INCCOM0.48%$3M81.6K
37EXPEAGLE MATLS INCCOM0.46%$2M18.6K
38ALUSSA ENERGY ACQUISITION COSHS CL A0.44%$2M237.0K
39SUMMIT MATLS INCCL A0.43%$2M82.9K
40IMMATICS N.VSHS0.32%$2M153.0K
41NEXIMMUNE INCCOM0.32%$2M89.5K
42JDJD.COM INCSPON ADR CL A0.31%$2M20.0K
43OPCHOPTION CARE HEALTH INCCOM NEW0.25%$1M74.6K
44APLTAPPLIED THERAPEUTICS INCCOM0.23%$1M67.1K
45AFIBACUTUS MED INCCOM0.18%$961,00071.8K
46ARYA SCIENCES ACQU CORP IVCL A0.04%$209,00020.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2021$176M18Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$595M45Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$539M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$854M58Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020REVEALED$578M37Nov 18, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2020$383M30Nov 18, 2020RESTATEMENTchanges · EDGAR ↗
Q1 2020$423M31May 15, 2020RESTATEMENTchanges · EDGAR ↗
Q4 2019$436M48Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$536M63Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$805M86Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$692M86May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.